Home › Funds › Gagnon Advisors, LLC › CDNA
Gagnon Advisors, LLC position in CDNA
CAREDX INC · Health Care
Gagnon Advisors, LLC reported holding 286,889 shares of CDNA (CAREDX INC) in its Q3 2026 13F filing — a position valued at US$18.6M, representing 10.24% of its reported portfolio and ranking #1 among its reported holdings. Gagnon Advisors, LLC has disclosed CDNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Gagnon Advisors, LLC's CDNA position evolved
Gagnon Advisors, LLC first disclosed a stake in CDNA in Q3 2023 at 554,851 shares (US$3.9M). The position peaked in Q3 2026 at 286,889 shares, worth US$18.6M. Across 13 filings, Gagnon Advisors, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 286,889 shares valued at US$18.6M — a reduction of -260,004 shares quarter over quarter.. Notable position changes include a 32% trim in Q3 2024 (shares fell 31% over the following quarter), a 48% trim in Q3 2026 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 554.85K | $3.88M | New |
| Q4 2023 | 554.85K | $6.66M | Hold |
| Q1 2024 | 610.34K | $6.46M | Add |
| Q2 2024 | 610.34K | $9.48M | Hold |
| Q3 2024 | 412.88K | $12.89M | Reduce |
| Q4 2024 | 412.88K | $8.84M | Hold |
| Q1 2025 | 412.88K | $7.33M | Hold |
| Q2 2025 | 454.16K | $8.87M | Add |
| Q3 2025 | 529.41K | $7.70M | Add |
| Q4 2025 | 532.89K | $10.04M | Add |
| Q1 2026 | 532.89K | $9.25M | Hold |
| Q2 2026 | 546.89K | $15.59M | Add |
| Q3 2026 | 286.89K | $18.65M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CDNA and 13F data
CDNA (CAREDX INC) is a Health Care company. 45 other funds we track also report a position in CDNA — the largest reported positions include ARK Invest (US$104.6M), GAGNON SECURITIES LLC (US$69.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$56.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CDNA
- ARK Invest 1.61M sh · $104.59M · Q3 2026
- GAGNON SECURITIES LLC 1.07M sh · $69.84M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 2.00M sh · $56.93M · Q2 2026
- Amova Asset Management Americas, Inc. 625.42K sh · $40.63M · Q3 2026
- Ophir Asset Management Pty Ltd 1.26M sh · $36.05M · Q2 2026
- BRAIDWELL LP 1.22M sh · $34.79M · Q2 2026
- Blue Water Life Science Advisors, LP 1.19M sh · $33.91M · Q2 2026
- Zweig-DiMenna Associates LLC 389.81K sh · $25.34M · Q3 2026
- Divisadero Street Capital Management, LP 700.94K sh · $19.98M · Q2 2026
- Portolan Capital Management, LLC 684.80K sh · $19.52M · Q2 2026
- Palo Alto Investors LP 531.87K sh · $15.16M · Q2 2026
More on Gagnon Advisors, LLC
FAQ
How long has Gagnon Advisors, LLC held CDNA?
Gagnon Advisors, LLC has disclosed CDNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Gagnon Advisors, LLC's current position in CDNA?
As of Q3 2026, Gagnon Advisors, LLC holds 286.89K shares of CDNA (CAREDX INC), valued at $18.65M, representing 10.24% of its reported portfolio and ranking #1.
Has Gagnon Advisors, LLC been buying or selling CDNA?
In the latest 13F filing (Q3 2026), Gagnon Advisors, LLC reduced its position in CDNA. The position peaked in Q3 2026 at 286.89K shares.
Which other funds hold CDNA?
Other major institutional holders of CDNA include ARK Invest, GAGNON SECURITIES LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.